Lv2
115 积分 2022-04-05 加入
State-of-the-art and upcoming trends in RAS-directed therapies in gastrointestinal malignancies
1个月前
已完结
Breakthrough in RAS targeting with pan-RAS(ON) inhibitors RMC-7977 and RMC-6236
1个月前
已完结
307 (PB295): The RAS(ON) multi-selective inhibitor RMC-6236 synergizes with TCelldirected immunotherapies to extend durability of antitumor activity in preclinical RAS-driven cancer models
1个月前
已完结
Pan-RAS inhibitor daraxonrasib shows promise in pancreatic cancer
1个月前
已完结
Pan-RAS Inhibitor RMC-6236 Suppresses Myeloma Growth and Shows Enhanced Efficacy with SWI/SNF Inhibition
1个月前
已关闭
Pan-RAS Inhibitor RMC-6236 Suppresses Myeloma Growth and Shows Enhanced Efficacy with SWI/SNF Inhibition
1个月前
已关闭
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated Melanoma
1个月前
已关闭
296 RASolve 301 Trial in Progress: A Phase 3 Study of Daraxonrasib (RMC-6236) vs. Docetaxel in Patients with Previously Treated RAS-Mutant Non-Small Cell Lung Cancer (NSCLC)
1个月前
已关闭
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated Melanoma
1个月前
已关闭
Abstract PR009: The RAS(ON) multi-selective inhibitor, daraxonrasib (RMC-6236), induces Receptor Tyrosine Kinase (RTK) cell surface expression on pancreatic cancer cells, providing rationale for combinations with RTK targeting agents
1个月前
已关闭
Multi-omics and functional analyses in Aesculus wilsonii elucidate the biosynthetic pathways of moretane- and oleanane-type triterpenoids
1个月前
已采纳
ALK-Positive Histiocytosis—A Distinct Histiocytic Entity Deserving Recognition—Reply
1个月前
已采纳
A Bio-inspired Energy-Efficient Routing Protocol based on Penguins Search Optimization for FANETs
1个月前
已驳回
When Is a Positive Test for Pediatric Growth Hormone Deficiency a True-Positive Test?
1个月前
已采纳
Normative High-Resolution Pharyngeal Manometry: Impact of Age, Size of System, and Sex on Primary Metrics and Pressure Stability
1个月前
已采纳
Paradoxical Psoriasis
1个月前
已采纳
皖公网安备34019202002308
